• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
Cigna Ventures | Health Care Venture Capital

Cigna Ventures | Health Care Venture Capital

  • Strategy
  • Partners
  • Team
  • Case Studies
  • News
  • Contact

News

MedAvail and MYOS RENS Technology Announce Closing of Business Combination

November 18, 2020

MedAvail, Inc. (“MedAvail”), a leading technology-enabled pharmacy organization that embeds pharmacy services directly into clinics and other points of care through its proprietary technology, announced the completion of its previously announced business combination with MYOS RENS Technology, Inc. (NASDAQ: MYOS), an advanced nutrition company and the owner of Fortetropin®, a proprietary bioactive composition that helps […]

READ MORE

Filed Under: News, Partnership Activity

Cigna Ventures, Humana, and Optum Ventures Among Investor Set Re-Upping in Buoy Health Series C Financing

November 10, 2020

Buoy Health, the AI-powered healthcare navigation platform, announced the completion of a $37.5 million Series C funding round. Cigna Ventures and Humana led the funding round and were joined by Optum Ventures, WR Hambrecht + Co, and Trustbridge Partners. To date, Buoy has raised $66.5 million. Read the full article

READ MORE

Filed Under: News

Datavant Brings in $40M to Power Health Data Exchange Across Providers, Life Sciences

October 12, 2020

Datavant, a data sharing technology startup for providers and life science companies, last week closed $40 million in Series B funding. Transformation Capital headlined the raise, which saw contributions from new backers Johnson & Johnson Innovation – JJDC and Cigna Ventures in addition to those of prior investors Roivant Sciences and Flex Capital. Read the […]

READ MORE

Filed Under: News, Partnership Activity

StartUPDATES: New Developments for Healthcare Startups

October 9, 2020

Datavant, a health IT company, received $40 million in Series B funding. Transformation Capital led the round with participation by new investors Johnson & Johnson Innovation – JJDC, Inc. and Cigna Ventures. Existing shareholders also took part, including Roivant Sciences and Flex Capital. Datavant’s technology enables a match between a consenting patient’s study data and […]

READ MORE

Filed Under: News, Partnership Activity

Mental Health Startup Ginger Lands $50M Backed by Cigna, Kaiser Permanente

August 6, 2020

“At Cigna Ventures, we are committed to investing in bold, new ways to make high-quality healthcare simpler and more affordable,” Sahil Choudhry, managing director at Cigna Ventures, said in a statement. Read the full article

READ MORE

Filed Under: News, Partnership Activity

On-Demand Mental Health Service Provider Ginger Raises $50 Million

August 6, 2020

The company’s $50 million Series D round was co-led by Advance Venture Partners and Bessemer Venture Partners, with additional participation from Cigna Ventures and existing investors such as Jeff Weiner, executive chairman of LinkedIn, and Kaiser Permanente Ventures. To date, Ginger has raised roughly $120 million. Read the full article

READ MORE

Filed Under: News, Partnership Activity

  • « Go to Previous Page
  • Page 1
  • Interim pages omitted …
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Go to Next Page »

Primary Sidebar

Categories

  • News
  • Partnership Activity

More news

  • Autonomize AI Raises $28 Million Series A to Power Next-Generation Agentic AI for Healthcare and Life Sciences June 19, 2025
  • Evernorth’s New Behavioral Care Practice Offers Quality Care To Improve Mental Well-Being March 13, 2024
  • 9amHealth Raises $9.5M Series A Extension Led by The Cigna Group Ventures to Expand to Employers Nationwide February 20, 2024
  • Prognos Health Raises $23 Million May 11, 2023
  • Monogram Health’s In-Home Services Now Available to More Older Adults Living with Chronic Kidney Conditions February 7, 2023
  • NOCD Completes Additional Funding in its Quest to End the OCD Crisis January 31, 2023
  • Monogram Health Closes $375M Growth Capital Raise to Support Continued Expansion of Innovative In-Home Kidney and Polychronic Care Model January 13, 2023

Footer

  • Strategy
  • Partners
  • Team
  • Case Studies
  • News
  • Contact

By contacting The Cigna Group Ventures through this website, you agree and acknowledge that information you submit will not be considered or treated as confidential or proprietary unless and until a separate agreement is signed and that The Cigna Group Ventures and its affiliates are under no obligation to review your submission or to enter into any agreement, investment or transaction associated with the submission. In no event will The Cigna Group Ventures or any of its affiliates be limited in, or restricted from, the pursuit of any opportunities, either alone or with third parties.

The information contained herein does not constitute a distribution, an offer to sell or the solicitation of an offer to buy any securities in any jurisdiction in which such distribution or offer is not authorized. In particular, the information herein is not for distribution and does not constitute an offer to sell or the solicitation of any offer to buy any securities in the United States (U.S.) or for the benefit of any U.S. person (being residents of the United States or partnerships or corporations organized under the laws of the United States), nor in any other country.

The Cigna Group name, logo and other marks are owned by Cigna Intellectual Property, Inc.
Privacy Policy | Terms of Use | Accessibility | Cookie Settings
© 2024 The Cigna Group Ventures. All rights reserved.

This site is protected by Google's reCAPTCHA. Privacy Policy and Terms of Service apply.